HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.690
-0.050 (-1.82%)
At close: Jul 17, 2026, 4:00 PM EDT
2.700
+0.010 (0.37%)
After-hours: Jul 17, 2026, 7:58 PM EDT
HeartSciences Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HeartSciences stock has a consensus rating of "Buy" and an average price target of $10. The average 1-year stock price forecast is 271.75% higher than the current stock price, while the lowest is $8.00 (+197.40%) and the highest is $12 (+346.10%).
Price Target: $10 (+271.75%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HeartSciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Dec '25 | Mar '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $12 | Buy | Reiterates | $12 | +346.10% | Jul 1, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $8 | Buy | Maintains | $8 | +197.40% | Mar 23, 2026 |
Financial Forecast
Revenue This Year
4.30K
from 4.35K
Decreased by -1.15%
Revenue Next Year
357.50K
from 4.30K
Increased by 8,213.95%
EPS This Year
-3.38
from -9.34
EPS Next Year
-2.83
from -3.38
EPS and Forward PE are based on non-GAAP adjusted numbers.